Global Medical Devices Market 2018-2023: In 2018, Just 15

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
30
Global Medical Devices Market 2018-2023: In 2018, Just 15 Companies Earn Almost 52% of the Revenue in the Device Market

Dublin, Jan. 24, 2019 (GLOBE NEWSWIRE) -- The "The Global Market for Medical Devices, 9th Edition (40+ Specific Device Markets and 50 Country Markets Forecasted to 2023)" report has been added to ResearchAndMarkets.com's offering.

Global Market for Medical Devices provides a complete view of the medical device market and opportunity for medical device companies, competitors, and investors. As part of its coverage, this report contains market sizing and forecasts for the world medical device market and those of 50 countries, a survey of regulatory practices across the world, research and development spending, a look at the status of the hospital industry, key market drivers and limiters, and profiles of major device companies. The report's findings show that revenue growth at major companies has changed and as well most revenue forecasts. Emerging markets continue to help boost company revenues, but the double-digit growth of past years is no longer widely forecasted. Global Market for Medical Devices provides the following market data:

  • Global Medical Device Market, 2016-2023
  • Global Markets for Specific Medical Devices, 2018-2023
  • Country Device Markets, 2018-2023 (United States, Germany, Japan, China, France, United Kingdom, Italy, Spain, Canada, Australia, India, Brazil, Netherlands, Switzerland, Taiwan, Mexico, S. Korea, Sweden, Turkey, Singapore, New Zealand, Saudi Arabia, Russia, Egypt, Malaysia, Thailand, Poland, Philippines, Indonesia, Argentina, Israel, Greece, South Africa, Chile, Vietnam, Bangladesh, Slovakia, UAE, Czech Republic, Romania, Iran, Venezuela, Slovenia, Ukraine, Lithuania, Croatia, Bulgaria, Iraq, Hungary, Serbia)
  • Medical Device Spending as a Percentage of Total Health Spending, by Country, 2018 Estimates (United States, Canada, Germany, France, Italy, United Kingdom, Spain, Turkey, Poland, Romania, Sweden, Switzerland, Netherlands, Greece, Hungary, Russia, Bulgaria, Croatia, Czech. Rep., Serbia, Ukraine, Lithuania, Slovakia, Slovenia, South Africa, Saudi Arabia, Egypt, Israel, Iran, Iraq, UAE, Japan, China, Australia, Vietnam, S. Korea, Malaysia, India, Indonesia, Singapore, Brazil, Mexico, Chile, Argentina, Venezuela)
  • Medical Device Market Distribution by Region, 2018 (%) (Northern America, EMEA, Asia Pacific, Latin America)

Specific Device Markets While there are hundreds of types of products that can be classified as medical devices, a few specific categories and products make up the bulk of the market. The report addresses device category segment markets, detailing the size of the global market for specific device markets in 2018 and an estimated market for 2023, including the following:

  • Anesthesia Monitors
  • Blood Collection
  • Blood Gas Analyzers
  • Blood Pressure Monitors
  • Cannula Respiratory
  • Catheters
  • Computed Tomography
  • Coronary Stents
  • CPAP Machines
  • Defibrillators
  • Dental Equipment/Devices (excluding x-ray)
  • Dental Implants/Components
  • Dental X-ray
  • Dialysis Equipment & Supplies
  • EKG/ECG Machines
  • Electrosurgical Devices
  • Endoscopes (excluding gastro)
  • Gastric Banding/Bariatric
  • Gastro Endoscopes
  • Glucose Tests
  • Hip implants
  • Hypodermic Syringe
  • Infusion Pumps
  • Intraocular Lenses
  • Knee implants
  • Medical Beds
  • Minimally Invasive Surgical Instruments
  • MRI
  • Neurostimulation
  • Ostomy Care Devices
  • Oxygen Therapy Equipment
  • Pacemakers
  • Personal protective equipment (gloves, masks, gowns)
  • Spine implants
  • Sport, Extremity and Trauma
  • Stethoscopes
  • Sutures, Staples, Staplers
  • Traditional Surgical Instruments (scalpels, forceps, retractors, scissors)
  • Ultrasound
  • Vascular Closure Devices
  • Wheelchairs
  • Wound Care, Advanced
  • X-Ray (excluding dental)

Top Companies In 2018, just 15 companies earn almost 52% of the revenue in the device market. Most companies operate in just a few markets, though the top companies are multi-billion-dollar companies that operate in several categories. In each edition of this report, The publisher has looked at those companies in the industry that are large, global, and representative of different categories of medical device. The operations of these companies provide insight into the performance of the global device market and reveal trends in geographic sales distribution and research and development spending. The following companies make up the publisher's Index of Bellwether Device Companies, with details of each related to performance in 2017 and 2018 included in the report:

  • Medtronic
  • Johnson & Johnson
  • Abbott
  • Danaher Corporation
  • Becton Dickinson & Co. (BD)
  • Siemens Healthineers
  • Stryker Corporation
  • Royal Philips
  • GE Healthcare
  • Boston Scientific
  • B. Braun
  • Zimmer Biomet
  • Baxter International
  • Olympus Medical Systems
  • Smith & Nephew Plc

Market by Country Global Market for Medical Devices evaluates country markets for medical devices, providing market size 2018-2023, annual growth 2017-2018, and medical device market indicators (such as population, urban population (% of total) 2018, life expectancy at birth (years) 2018, total health spending (billions$), health spending % of GDP, physicians (per 1000 inhabitants), hospital beds (per 1000 inhabitants), diabetes prevalence (% of Population) 2017, and primary causes of death) for the top 20 country markets:

  • United States
  • Germany
  • Japan
  • China
  • France
  • United Kingdom
  • Italy
  • Spain
  • Canada
  • Australia
  • India
  • Brazil
  • Netherlands
  • Switzerland
  • Taiwan
  • Mexico
  • South Korea
  • Sweden
  • Turkey
  • Singapore

Mergers and Acquisitions During the years 2015 through 2017 and through the first three quarters of 2018, key market players were active in M&A. Market share position has changed in the last year as several major competitors merged and others have shed medical device units. Medical device companies are seeking strategic acquisitions to fill gaps in their portfolios in a manner that will help them offer more complete solutions. There is a trend toward consolidation, driven in part by the necessity to reduce costs as pricing pressures mount from hospital customers. The report contains a select listing of major mergers and acquisitions that occurred in the medical device market in since 2015. Company Profiles Global Market for Medical Devices provides profiles not only of the 15 bellwether market companies based on revenues and diversity of medical devices produced, but also of other major concerns in the medical device market, including:

  • 3M Health Care
  • Access Scientific, LLC
  • Acelity L.P. Inc.
  • Advanced Bionics AG
  • Angiodynamics
  • Arjo AB
  • Arthrex, Inc.
  • Asahi Kasei
  • BSN medical GmbH - Essity
  • Cardinal Health
  • Coloplast A/S
  • CONMED Corporation
  • Convatec
  • Cook Medical
  • Cooper Surgical
  • Dentsply-Sirona
  • Drgerwerk AG & Co. KGaA
  • Drive DeVilbiss Healthcare
  • Edwards Lifesciences Corp.
  • Fisher & Paykel Healthcare Limited
  • Fresenius
  • GF Health Products Inc.
  • Haemonetics
  • Hill-Rom
  • Hollister Incorporated
  • Invacare
  • IRadimed Corporation
  • Masimo Corporation
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Mlnlycke Health Care AB
  • Nova Biomedical
  • Paul Hartmann, AG
  • PerkinElmer, Inc
  • ResMed
  • Roche
  • Teleflex Inc
  • Terumo Corporation
  • Varian Medical Systems, Inc.
  • Vyaire Medical
  • Zyno Medical LLC

For the purposes of this report, the definition of a medical device is a broad one. A medical device is a product that is used in treatment, diagnosis or injury repair in a patient that does not achieve its effect through chemical action or metabolism in the human body. Most importantly, they are devices that are regulated. Because of the broad definition, estimates of medical device markets vary, as any item from a nuclear camera or catheter to a latex glove can be considered a medical device. It is, as a result, a market in which hundreds of companies worldwide participate.

For more information about this report visit https://www.researchandmarkets.com/research/v...dical?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Medical Devices

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading